PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,431 | -45.1% | 7,274 | -24.2% | 0.00% | – |
| Q2 2023 | $137,443 | +307.3% | 9,598 | +103.1% | 0.00% | – |
| Q1 2023 | $33,744 | +574.9% | 4,726 | +1061.2% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 407 | -32.1% | 0.00% | – |
| Q2 2022 | $5,000 | -77.3% | 599 | -62.7% | 0.00% | – |
| Q1 2022 | $22,000 | -87.3% | 1,605 | -81.7% | 0.00% | – |
| Q4 2021 | $173,000 | +31.1% | 8,793 | +149.3% | 0.00% | – |
| Q1 2021 | $132,000 | -64.8% | 3,527 | -68.8% | 0.00% | – |
| Q4 2020 | $375,000 | +18.7% | 11,289 | +30.9% | 0.00% | – |
| Q3 2020 | $316,000 | -16.6% | 8,627 | -25.0% | 0.00% | – |
| Q2 2020 | $379,000 | +132.5% | 11,507 | +82.7% | 0.00% | – |
| Q1 2020 | $163,000 | +503.7% | 6,299 | +619.1% | 0.00% | – |
| Q4 2019 | $27,000 | – | 876 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |